Yantai Zhenghai Biotechnology Past Earnings Performance
Past criteria checks 3/6
Yantai Zhenghai Biotechnology has been growing earnings at an average annual rate of 15.4%, while the Biotechs industry saw earnings growing at 5.4% annually. Revenues have been growing at an average rate of 12.3% per year. Yantai Zhenghai Biotechnology's return on equity is 18%, and it has net margins of 45.1%.
Key information
15.4%
Earnings growth rate
18.4%
EPS growth rate
| Biotechs Industry Growth | 11.3% |
| Revenue growth rate | 12.3% |
| Return on equity | 18.0% |
| Net Margin | 45.1% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Yantai Zhenghai Biotechnology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 394 | 178 | 128 | 40 |
| 31 Dec 23 | 414 | 191 | 132 | 44 |
| 30 Sep 23 | 414 | 178 | 140 | 44 |
| 30 Jun 23 | 426 | 191 | 140 | 44 |
| 31 Mar 23 | 425 | 184 | 141 | 42 |
| 01 Jan 23 | 433 | 185 | 146 | 38 |
| 30 Sep 22 | 440 | 197 | 150 | 39 |
| 30 Jun 22 | 431 | 192 | 147 | 38 |
| 31 Mar 22 | 416 | 180 | 149 | 36 |
| 31 Dec 21 | 400 | 169 | 152 | 35 |
| 30 Sep 21 | 378 | 149 | 157 | 32 |
| 30 Jun 21 | 360 | 144 | 148 | 30 |
| 31 Mar 21 | 351 | 143 | 144 | 29 |
| 31 Dec 20 | 293 | 118 | 126 | 27 |
| 30 Sep 20 | 295 | 123 | 122 | 24 |
| 30 Jun 20 | 282 | 111 | 126 | 22 |
| 31 Mar 20 | 263 | 100 | 126 | 22 |
| 31 Dec 19 | 280 | 107 | 131 | 21 |
| 30 Sep 19 | 251 | 100 | 119 | 19 |
| 30 Jun 19 | 243 | 97 | 114 | 18 |
| 31 Mar 19 | 230 | 91 | 107 | 18 |
| 31 Dec 18 | 216 | 86 | 100 | 17 |
| 30 Sep 18 | 216 | 88 | 96 | 17 |
| 30 Jun 18 | 204 | 81 | 87 | 25 |
| 31 Mar 18 | 193 | 76 | 88 | 19 |
| 31 Dec 17 | 183 | 62 | 95 | 16 |
| 30 Sep 17 | 176 | 54 | 100 | 12 |
| 30 Jun 17 | 164 | 47 | 106 | 0 |
| 31 Mar 17 | 159 | 46 | 102 | 0 |
| 31 Dec 16 | 151 | 45 | 95 | 0 |
| 30 Jun 16 | 138 | 43 | 89 | 0 |
| 31 Mar 16 | 126 | 41 | 81 | 0 |
| 31 Dec 15 | 128 | 42 | 80 | 0 |
| 31 Dec 14 | 105 | 34 | 65 | 0 |
| 31 Dec 13 | 77 | 16 | 52 | 0 |
Quality Earnings: 300653 has high quality earnings.
Growing Profit Margin: 300653's current net profit margins (45.1%) are higher than last year (43.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300653's earnings have grown by 15.4% per year over the past 5 years.
Accelerating Growth: 300653's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 300653 had negative earnings growth (-3.2%) over the past year, making it difficult to compare to the Biotechs industry average (-3.2%).
Return on Equity
High ROE: 300653's Return on Equity (18%) is considered low.